PHIBRO ANIMAL HEALTH CORP-A (PAHC) Stock Price, Forecast & Analysis
USA - NASDAQ:PAHC - US71742Q1067 - Common Stock
PAHC Key Statistics, Chart & Performance
The current stock price of PAHC is 45.1 USD. In the past month the price increased by 13.54%. In the past year, price increased by 84.38%.
PAHC Latest News, Press Relases and Analysis
PAHC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 46.62 | 970.39B | ||
| JNJ | JOHNSON & JOHNSON | 18.88 | 471.87B | ||
| MRK | MERCK & CO. INC. | 10.55 | 232.09B | ||
| PFE | PFIZER INC | 7.83 | 142.48B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.11 | 94.95B | ||
| ZTS | ZOETIS INC | 19.06 | 53.55B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.53 | 22.84B | ||
| VTRS | VIATRIS INC | 4.6 | 12.50B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.97 | 10.48B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.84 | 7.96B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.97B | ||
| LGND | LIGAND PHARMACEUTICALS | 27.55 | 3.94B |
Related stock screener links
About PAHC
Company Profile
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 2,475 full-time employees. The company went IPO on 2014-04-11. The company develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. The company markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. The company has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Company Info
PHIBRO ANIMAL HEALTH CORP-A
Glenpointe Centre East, 3Rd Floor, 300 Frank W. Burr Blvd., Suite 21
Teaneck NEW JERSEY 07666 US
CEO: Jack C. Bendheim
Employees: 1940
Phone: 12013297300
PHIBRO ANIMAL HEALTH CORP-A / PAHC FAQ
Can you describe the business of PHIBRO ANIMAL HEALTH CORP-A?
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 2,475 full-time employees. The company went IPO on 2014-04-11. The company develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. The company markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. The company has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Can you provide the latest stock price for PHIBRO ANIMAL HEALTH CORP-A?
The current stock price of PAHC is 45.1 USD. The price increased by 0.89% in the last trading session.
Does PAHC stock pay dividends?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) has a dividend yield of 1.07%. The yearly dividend amount is currently 0.48.
What is the ChartMill technical and fundamental rating of PAHC stock?
PAHC has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the valuation of PHIBRO ANIMAL HEALTH CORP-A (PAHC) based on its PE ratio?
The PE ratio for PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 18.26. This is based on the reported non-GAAP earnings per share of 2.47 and the current share price of 45.1 USD.
Can you provide the growth outlook for PHIBRO ANIMAL HEALTH CORP-A?
The Revenue of PHIBRO ANIMAL HEALTH CORP-A (PAHC) is expected to grow by 14.11% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for PAHC stock?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) will report earnings on 2026-02-03.
PAHC Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to PAHC. When comparing the yearly performance of all stocks, PAHC is one of the better performing stocks in the market, outperforming 94.84% of all stocks.
PAHC Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PAHC. PAHC scores excellent on profitability, but there are some minor concerns on its financial health.
PAHC Financial Highlights
Over the last trailing twelve months PAHC reported a non-GAAP Earnings per Share(EPS) of 2.47. The EPS increased by 76.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.85% | ||
| ROA | 4.89% | ||
| ROE | 21.76% | ||
| Debt/Equity | 2.32 |
PAHC Forecast & Estimates
9 analysts have analysed PAHC and the average price target is 33.32 USD. This implies a price decrease of -26.12% is expected in the next year compared to the current price of 45.1.
For the next year, analysts expect an EPS growth of 28.48% and a revenue growth 14.11% for PAHC